Search
News
COVID-19 During Pregnancy Associated with Preterm Birth, UCSF-Led Study Finds
Pregnant people infected with COVID-19 face an increased risk of very preterm birth (VPTB), preterm birth (PTB) or early term birth, according to a large population-based study led by researchers at UC San Francisco.
Video
Advances (and Uncertainties) in Oncology: Current and Future Roles of Antibody Drug Conjugates
Focusing on common bladder, lung and breast cancers, three UCSF oncologists describe how antibody drug conjugates (ADCs) are changing the treatment landscape, especially for refractory cases
Video
Ross Procedure for Aortic Valve Disease: Why It's the Superior Option in Younger Patients
Cardiac surgeon Marko T. Boskovski, MD, MHS, MPH, provides compelling data on the ultimate failure of traditional valve replacements to support the lifespan of physically active non-elderly adults and describes the value of the Ross procedure.
Video
CAR T-Cells for Hematologic Malignancies and Beyond
In this data-drenched discussion, UCSF specialists review how CAR T-cells are being used in hematologic malignancies, including aggressive lymphoma and difficult-to-treat myeloma, as well as for solid tumors, and reveal what's on the horizon with regard to these products.
News
Drug Targeting Tauopathies in Mice Reveals Sex Differences in Response
Microglia are cells that are central to both brain health as well as disease progression in many neurological conditions.
News
UCSF Surgical Oncologists Present Clinical Findings at International Conference
The latest advances in surgical cancer care and research were showcased at the Society of Surgical Oncology’s (SSO) Annual Meeting, the International Conference on Surgical Cancer Care. The meeting was held in Boston, from March 22 – 25, 2023.
Video
Meet the Doctor: Dr. Christina Allen
Get to know Dr. Christina Allen, an Orthopedics Sports Medicine surgeon at UCSF.
News
Olfactory Loss from COVID-19 Infection: Cause and Treatments Studied at UCSF
Complete (anosmia) and incomplete (hyposmia) smell sensitivity impairment are widely reported indicators among the many symptoms of COVID-19 infection. Quality of life can be substantially impacted by the loss of taste and smell, with possible effects including depression, loss of appetite, and safety risks from lack of awareness of gas leaks, smoke or spoiled food. The path to recovery of taste and smell varies widely among affected individuals.
News
International Conference Features UCSF Breast Cancer Experts
Breast cancer experts from UCSF Health will present new research and clinical findings at the annual San Antonio Breast Cancer Symposium, the world’s largest and most prestigious breast cancer conference.
Video
A Better Understanding of Breast Cancer Risk: How to Find the Best Options for Individual Patients
Doctors must weigh numerous factors as they seek to identify and manage patients at high breast cancer risk.
Video
COVID Update: Experts Answer Questions on Boosters, Everyday Risks and What the Future Holds
An expert panel mines the latest data to discuss the COVID-related issues on patients’ minds
News
Forecasting May Help People with Epilepsy Predict Their Seizures
UCSF team discovers brain activity patterns that foreshadow seizures up to 24 hours before they occur.
Video
Our Cardiologists Address Consequences of the COVID Crisis
The pandemic has both led to delays in heart attack treatment and highlighted racial disparities in health care. Our specialists look at facts and possible solutions. Plus: an update on managing COVID patients at risk of thrombosis and other inflammatory conditions.
Video
Screening for Breast Cancer in an Era of Breast Density Legislation
Get an in-depth look at evidence for mammography as a screening tool to reduce mortality via early detection of breast cancer. Also: the value of breast density legislation, density assessments and supplemental screening options like MRI and ultrasound.
News
UCSF and I-SPY 2 Breast Cancer Researchers Develop Newly Redefined Breast Cancer Response Subtypes
Research scientists and statisticians from UC San Francisco have developed improved biomarker classifications as part of their research results in the I-SPY 2 trial for high-risk breast cancer patients.
Document
Breast Oncology
Expert care and transformative research working together to improve both survival and quality of life
News
UCSF’s Dr. Mitchel Berger on the Cancer Moonshot Relaunch
On Feb. 2, 2022, Mitchel Berger, MD, neurosurgeon and director of the UCSF Brain Tumor Center, attended the relaunch of the White House’s Cancer Moonshot initiative at the invitation of President Joe Biden and Dr. Jill Biden.
News
Pancreatic Cancer Patient Exceeds Life Expectancy After Complex Whipple Procedure at UCSF
A team of UCSF surgeons devised a successful reconstruction approach during a complex Whipple procedure in a 69-year-old man with locally advanced pancreatic adenocarcinoma.
News
Susceptibility to Pathogenic T Cells in Chronic Lung Disease May have a Genetic Basis
Respiratory viral infections pose significant morbidity and mortality to patients with chronic lung diseases like emphysema and COPD, causing exacerbations that drive destruction of normal lung tissue, and leading to one of the most common diagnoses for hospital admissions.
Video
Incidental Thyroid Nodules: Benign Bump or Big Deal?
A lump on the thyroid is a common finding in both physical exams and imaging studies, but the significance varies greatly.
Video
Treating Brain Aneurysms: How a Savvy Neurosurgical Team Individualizes Care
In this short video, vascular and endovascular surgeon Ethan Winkler, MD, PhD, explains the factors that go into determining the right treatment for different cases involving dangerously bulging blood vessels in the brain.
Video
Clearing the Confusion Over Prostate Cancer Screening
Doctors have backed off on routine use of the PSA test, yet prostate cancer remains the second most common fatal cancer in American men. Genitourinary oncologist Matthew R. Cooperberg, MD says that screening shouldn’t stop, it should be smarter
Document
Epilepsy Center
The UCSF Epilepsy Center is the Bay Area’s premier level 4 epilepsy center, the highest possible rating from the National Association of Epilepsy Centers.
News
Stephen Hauser Wins Breakthrough Prize for Role in Redefining MS
Neuro-immunologist Stephen Hauser, MD, whose maverick thinking transformed the treatment landscape for patients with multiple sclerosis (MS), has received the 2025 Breakthrough Prize in Life Sciences.
